The human obesity gene map: The 2002 update

Obesity Research

Volumn 11, Issue 3, 2003, Pages 313-367

  Chagnon, Yvon C ^a   Rankinen, Tuomo ^b   Snyder, Eric E ^b   Weisnagel, S John ^c   Pérusse, Louis ^c   Bouchard, Claude ^b  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Association; Human obesity gene map; Linkages; Mendelian disorders; Quantitative trait loci

Indexed keywords

ANIMALIA; MURINAE;

ANIMAL; CHROMOSOME MAP; CROSS BREEDING; GENETIC LINKAGE; GENETICS; GENOME; HUMAN; MUTATION; OBESITY; QUANTITATIVE TRAIT LOCUS; REVIEW;

ANIMALS; CHROMOSOME MAPPING; CROSSES, GENETIC; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); MUTATION; OBESITY; QUANTITATIVE TRAIT LOCI;

EID: 0037870174     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.47     Document Type: Review

References (592)

1. Bouchard C, Pérusse L. Current status of the human obesity gene map. Obes Res. 1996;4:81-90.
2. Pérusse L, Bouchard C. Identification of genes contributing to excess body fat and fat distribution. In: Angel A, Anderson H, Bouchard C, Lau D, Leiter L, Mendelson R, eds. 7th International Congress on Obesity. Progress in Obesity Research. Toronto: John Libbey & Company Ltd, London, England; 1996:281-9.
3. Pérusse L, Chagnon YC, Dionne FT, Bouchard C. The human obesity gene map: the 1996 update. Obes Res. 1997;5:49-61.
4. Chagnon YC, Pérusse L, Bouchard C. The human obesity gene map: the 1997 update. Obes Res. 1998;6:76-92.
5. Pérusse L, Chagnon YC, Weisnagel J, Bouchard C. The human obesity gene map: the 1998 update. Obes Res. 1999;7:111-29.
6. Chagnon YC, Pérusse L, Weisnagel JS, Rankinen T, Bouchard C. The human obesity gene map: the 1999 update. Obes Res. 2000;8:89-117.
7. Pérusse L, Chagnon YC, Weisnagel SJ, et al. The human obesity gene map: the 2000 update. Obes Res. 2001;9:135-69.
8. Rankinen T, Perusse L, Weisnagel SJ, Snyder EE, Chagnon YC, Bouchard C. The human obesity gene map: the 2001 update. Obes Res. 2002;10:196-243.
9. Kobayashi H, Ogawa Y, Shintani M, et al. A Novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Diabetes. 2002;51:243-6.
10. Jacobson P, Ukkola O, Rankinen T, et al. Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort. J Clin Endocrinol Metab. 2002;87:4442-6.
11. Lee YS, Poh LK, Loke KY. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab. 2002;87:1423-6.
12. Peterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fid mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet. 2001;27:121-4.
13. Fumakoshi AMK, Shinozaki H, Masada M, Kawanami T, Takata Y, Komo A. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem Biophys Res Commun. 1993;210:787-96.
14. Schwartz GJ, Whitney A, Skoglund C, Castonguay TW, Moran TH. Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors. Am J Physiol. 1999;277:R1144-51.
15. Donahue LR, Beamer WG. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J Endocrinol. 1993;136:91-104.
16. Shackleton S, Lloyd DJ, Jackson SN, et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 2000;24:153-6.
17. Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000;9:109-12.
18. Speckman RA, Garg A, Du F, et al. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet. 2000;66:1192-8.
19. Garg A, Vinaitheerthan M, Weatherall PT, Bowcock AM. Phenotypic heterogeneity in patients with familial partial lipodystrophy (Dunnigan variety) related to the site of missense mutations in lamin a/c gene. J Clin Endocrinol Metab. 2001;86:59-65.
20. Agarwal AK, Garg A. A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab. 2002;87:408-11.
21. Biswas S, Munier FL, Yardley J, et al. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet. 2001;10:2415-23.
22. Meguro M, Mitsuya K, Nomura N, et al. Large-scale evaluation of imprinting status in the Prader-Willi syndrome region: an imprinted direct repeat cluster resembling small nucleolar RNA genes. Hum Mol Genet. 2001;10:383-94.
23. Gallagher RC, Pils B, Albalwi M, Francke U. Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet. 2002;71:669-78.
24. Turleau C, Demay G, Cabanis MO, Lenoir G, de Grouchy J. 6q1 monosomy: a distinctive syndrome. Clin Genet. 1988;34:38-42.
25. Roland B, Lowry RB, Cox DM, Ferreira P, Lin CC. Familial complex chromosomal rearrangement resulting in duplication/deletion of 6q14 to 6q16. Clin Genet. 1993;43:117-21.
26. Villa A, Urioste M, Bofarull JM, Martinez-Frias ML. De novo interstitial deletion q16.2-q21 on chromosome 6. Am J Med Genet. 1995;55:379-83.
27. Stein CK, Stred SE, Thomson LL, Smith FC, Hoo JJ. Interstitial 6q deletion and Prader-Willi-like phenotype. Clin Genet. 1996;49:306-10.
28. Smith A. The diagnosis of Prader-Willi syndrome. J Paediatr Child Health. 1999;35:335-7.
29. Gilhuis HJ, van Ravenswaaij CM, Hamel BJ, Gabreels FJ. Interstitial 6q deletion with a Prader-Willi-like phenotype: a new case and review of the literature. Eur J Paediatr Neurol. 2000;4:39-43.
30. Faivre L, Cormier-Daire V, Lapierre JM, et al. Deletion of the SIM1 gene (6q16.2) in a patient with a Prader-Willi-like phenotype. J Med Genet. 2002;39:594-6.
31. Marlin S, Couet D, Lacombe D, Cessans C, Bonneau D. Obesity: a new feature of WAGR (del 11p) syndrome. Clin Dysmorphol. 1994;3:255-7.
32. Tiberio G, Digilio MC, Giannotti A. Obesity and WAGR syndrome. Clin Dysmorphol. 2000;9:63-4.
33. Gul D, Ogur G, Tunca Y, Ozcan O. Third case of WAGR syndrome with severe obesity and constitutional deletion of chromosome (11)(p12p14). Am J Med Genet. 2002;107:70-1.
34. Hearn T, Renforth GL, Spalluto C, et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nat Genet. 2002;31:79-83.
35. Collin GB, Marshall JD, Ikeda A, et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet. 2002;31:74-8.
36. Mykytyn K, Nishimura DY, Searby CC, et al. Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet. 2002;31:435-8.
37. Katsanis N, Eichers ER, Ansley SJ, et al. BBS4 is a minor contributor to Bardet-Biedl syndrome and may also participate in triallelic inheritance. Am J Hum Genet. 2002;71:22-9.
38. Slavotinek AM, Searby C, Al-Gazali L, et al. Mutation analysis of the MKKS gene in McKusick-Kaufman syndrome and selected Bardet-Biedl syndrome patients. Hum Genet. 2002;110:561-7.
39. Agarwal AK, Arioglu E, De Almeida S, et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet. 2002;31:21-3.
40. Kivitie-Kallio S, Norio R. Cohen syndrome: essential features, natural history, and heterogeneity. Am J Med Genet. 2001;102:125-35.
41. Santer R, Groth S, Kinner M, et al. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum Genet. 2002;110:21-9.
42. Lower KM, Turner G, Kerr BA, et al. Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nat Genet. 2002;4:4.
43. Leshinsky-Silver E, Zinger A, Bibi CN, et al. MEHMO (mental retardation, epileptic seizures, hypogenitalism, microcephaly, obesity): a new X-linked mitochondrial disorder. Eur J Hum Genet. 2002;10:226-30.
44. Anunciado RV, Nishimura M, Mori M, et al. Quantitative trait loci for body weight in the intercross between SM/J and A/J mice. Exp Anim. 2001;50:319-24.
45. Tanomura H, Miyake T, Taniguchi Y, et al. Detection of a quantitative trait locus for intramuscular fat accumulation using the OLETF rat. J Vet Med Sci. 2002;64:45-50.
46. Wada Y, Akita T, Awata T, et al. Quantitative trait loci (QTL) analysis in a Meishan X Gottingen cross population. Anim Genet. 2000;31:376-84.
47. MacNeil MD, Grosz MD. Genome-wide scans for QTL affecting carcass traits in Hereford X composite double backcross populations. J Anim Sci. 2002;80:2316-24.
48. van Kaam JB, Groenen MA, Bovenhuis H, Veenendaal A, Vereijken AL, van Arendonk JA. Whole genome scan in chickens for quantitative trait loci affecting growth and feed efficiency. Poult Sci. 1999;78:15-23.
49. Tuiskula-Haavisto M, Honkatukia M, Vilkki J, de Koning DJ, Schulman NF, Maki-Tanila A. Mapping of quantitative trait loci affecting quality and production traits in egg layers. Poult Sci. 2002;81:919-27.
50. Wittenburg H, Lammert F, Wang DQ, et al. Interacting QTLs for cholesterol gallstones and gallbladder mucin in AKR and SWR strains of mice. Physiol Genomics. 2002;8:67-77.
51. Komatsu S, Kiyosawa H, Yoshiki A, et al. Identification of seven loci for static glucokinesis and dynamic glucokinesis in mice. Mamm Genome. 2002;13:293-8.
52. Shike T, Hirose S, Kobayashi M, Funabiki K, Shirai T, Tomino Y. Susceptibility and negative epistatic loci contributing to type 2 diabetes and related phenotypes in a KK/Ta mouse model. Diabetes. 2001;50:1943-8.
53. Plum L, Giesen K, Kluge R, et al. Characterisation of the mouse diabetes susceptibility locus Nidd/SJL: islet cell destruction, interaction with the obesity QTL Nob1, and effect of dietary fat. Diabetologia. 2002;45:823-30.
54. Leamy LJ, Pomp D, Eisen EJ, Cheverud JM. Pleiotropy of quantitative trait loci for organ weights and limb bone lengths in mice. Physiol Genomics. 2002;10:21-9.
55. Sugiyama F, Churchill GA, Li R, et al. QTL associated with blood pressure, heart rate, and heart weight in CBA/CaJ and BALB/cJ mice. Physiol Genomics. 2002;10:5-12.
56. Ciobanu D, Bastiaansen J, Malek M, et al. Evidence for new alleles in the protein kinase adenosine monophosphate-activated gamma(3)-subunit gene associated with low glycogen content in pig skeletal muscle and improved meat quality. Genetics. 2001;159:1151-62.
57. Perez-Enciso M, Clop A, Folch JM, et al. Exploring alternative models for sex-linked quantitative trait loci in outbred populations. Application to an Iberian X Landrace pig intercross. Genetics. 2002;161:1625-32.
58. Li C, Basarab J, Snelling WM, Benkel B, Murdoch B, Moore SS. The identification of common haplotypes on bovine chromosome 5 within commercial lines of Bos taurus and their associations with growth traits. J Anim Sci. 2002;80:1187-94.
59. The Jackson Laboratory. Mouse Genome Database (MGD). Bar Harbor, ME. http://www.jax.org
60. DeBry RW, Seldin MF. Human/mouse homology relationships. Genomics. 1996;33:337-51.
61. Yamada J, Kuramoto T, Serikawa T. A rat genetic linkage map and comparative maps for mouse or human homologous rat genes. Mamm Genome. 1994;5:63-83.
62. Jacob HJ, Brown DM, Bunker RK, et al. A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet. 1995;9:63-9.
63. Animal Research Genome Program. Animal Genome Database. http://ws4.niai.affrc.go.jp
64. National Animal Genome Research Program. U.S. Livestock Genome Mapping Projects. http://www.genome.iastate.edu
65. de Silva AM, Walder KR, Boyko EJ, et al. Genetic variation and obesity in Australian women: a prospective study. Obes Res. 2001;9:733-40.
66. Mattevi VS, Zembrzuski VM, Hutz MH. Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil. Int J Obes Relat Metab Disord. 2002;26:1179-85.
67. Korbonits M, Gueorguiev M, O'Grady E, et al. A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab. 2002;87:4005-8.
68. Gonzalez Sanchez JL, Serrano Rios M, Fernandez Perez C, Laakso M, Martinez Larrad MT. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol. 2002;147:495-501.
69. Menzaghi C, Ercolino T, Di Paola R, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002;51:2306-12.
70. Stumvoll M, Tschritter O, Fritsche A, et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes. 2002;51:37-41.
71. Esterbauer H, Oberkofler H, Linnemayr V, et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women. Diabetes. 2002;51:1281-6.
72. Yamada K, Yuan X, Otabe S, Koyanagi A, Koyama W, Makita Z. Sequencing of the putative promoter region of the cocaine- and amphetamine-regulated- transcript gene and identification of polymorphic sites associated with obesity. Int J Obes Relat Metab Disord. 2002;26:132-6.
73. Meirhaeghe A, Luan J, Selberg-Franks P, et al. The effect of the Gly16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity. J Clin Endocrinol Metab. 2001;86:5881-7.
74. Moore GE, Shuldiner AR, Zmuda JM, Ferrell RE, McCole SD, Hagberg JM. Obesity gene variant and elite endurance performance. Metabolism. 2001;50:1391-2.
75. Hoffstedt J, Andersson IL, Persson L, Isaksson B, Arner P. The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity. Diabetologia. 2002;45:584-7.
76. Marti A, Corbalan MS, Martinez-Gonzalez MA, Martinez JA. TRP64ARG polymorphism of the beta3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle. Diabetes Obes Metab. 2002;4:428-30.
77. Corbalan MS, Marti A, Forga L, Martinez-Gonzalez MA, Martinez JA. The risk of obesity and the Trp64Arg polymorphism of the beta(3)-adrenergic receptor: effect modification by age. Ann Nutr Metab. 2002;46:152-8.
78. Han Z, Heath SC, Shmulewitz D, et al. Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia. Am J Med Genet. 2002;110:234-42.
79. Dionne IJ, Garant MJ, Nolan AA, et al. Association between obesity and a polymorphism in the beta(1)-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women. Int J Obes Relat Metab Disord. 2002;26:633-9.
80. Gu D, O'Dell SD, Chen XH, Miller GJ, Day IN. Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11. Hum Genet. 2002;110:173-81.
81. Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC. Relationships between the TaqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf). 2001;55:605-11.
82. Poch E, Giner V, Gonzalez-Nunez D, Coll E, Oriola J, de la Sierra A. Association of the G protein beta3 subunit T allele with insulin resistance in essential hypertension. Clin Exp Hypertens. 2002;24:345-53.
83. Rosmond R, Bouchard C, Björntorp P. 5-HT(2A) receptor gene promoter polymorphism in relation to abdominal obesity and cortisol. Obes Res. 2002;10:585-9.
84. Iwai N, Katsuya T, Mannami T, et al. Association between SAH, an acyl-CoA synthetase gene, and hypertriglyceridemia, obesity, and hypertension. Circulation. 2002;105:41-7.
85. Argyropoulos G, Rankinen T, Neufeld DR, et al. A polymorphism in the human agouti-related protein is associated with late-onset obesity. J Clin Endocrinol Metab. 2002;87:4198-202.
86. Engert JC, Vohl MC, Williams SM, et al. 5′ flanking variants of resistin are associated with obesity. Diabetes. 2002;51:1629-34.
87. Philibert R, Caspers K, Langbehn D, et al. The association of a HOPA polymorphism with major depression and phobia. Compr Psychiatry. 2002;43:404-10.
88. Garenc C, Perusse L, Chagnon YC, et al. The alpha 2-adrenergic receptor gene and body fat content and distribution: the HERITAGE Family Study. Mol Med. 2002;8:88-94.
89. Roth SM, Schrager MA, Metter EJ, et al. IGF2 genotype and obesity in men and women across the adult age span. Int J Obes Relat Metab Disord. 2002;26:585-7.
90. Garenc C, Perusse L, Chagnon YC, et al. The hormone-sensitive lipase gene and body composition: the HERITAGE Family Study. Int J Obes Relat Metab Disord. 2002;26:220-7.
91. Boucher N, Lanouette CM, Larose M, Perusse L, Bouchard C, Chagnon YC. A +2138InsCAGACC polymorphism of the melanocortin receptor 3 gene is associated in human with fat level and partitioning in interaction with body corpulence. Mol Med. 2002;8:158-65.
92. Siani A, Iacone R, Russo O, et al. Gly40Ser polymorphism of the glucagon receptor gene is associated with central adiposity in men. Obes Res. 2001;9:722-6.
93. Ukkola O, Tremblay A, Sun G, Chagnon YC, Bouchard C. Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding. Eur J Clin Nutr. 2001;55:1008-15.
94. Kimm SY, Glynn NW, Aston CE, et al. Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am J Clin Nutr. 2002;75:714-9.
95. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (-2548 g/a) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res. 2002;34:355-9.
96. Hauner H, Rohrig K, Siffert W. Effects of the G-Protein beta3 subunit 825T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes. Horm Metab Res. 2002;34:475-80.
97. Ryden M, Faulds G, Hoffstedt J, Wennlund A, Arner P. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes. 2002;51:1601-8.
98. Chaves FJ, Giner V, Corella D, et al. Body weight changes and the A-6G polymorphism of the angiotensinogen gene. Int J Obes Relat Metab Disord. 2002;26:1173-8.
99. Sivenius K, Lindi V, Niskanen L, Laakso M, Uusitupa M. Effect of a three-amino acid deletion in the alpha2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects. Int J Obes Relat Metab Disord. 2001;25:1609-14.
100. Ellsworth DL, Coady SA, Chen W, et al. Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart Study. Int J Obes Relat Metab Disord. 2002;26:928-37.
101. Lanouette CM, Chagnon YC, Rice T, et al. Uncoupling protein 3 gene is associated with body composition changes with training in HERITAGE study. J Appl Physiol. 2002;92:1111-8.
102. Rankinen T, Rice T, Leon AS, et al. G protein beta 3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study. Physiol Genomics. 2002;8:151-7.
103. Xinli W, Xiaomei T, Meihua P, Song L. Association of a mutation in the beta3-adrenergic receptor gene with obesity and response to dietary intervention in Chinese children. Acta Paediatr. 2001;90:1233-7.
104. Lindi VI, Uusitupa MI, Lindstrom J, et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes. 2002;51:2581-6.
105. Reynolds GP, Zhang ZJ, Zhang XB. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet. 2002;359:2086-7.
106. Westberg L, Bah J, Rastam M, et al. Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls. Neuropsychopharmacology. 2002;26:789-93.
107. Hamer OW, Forstner D, Ottinger I, et al. The Pro115Gln polymorphism within the PPAR gamma2 gene has no epidemiological impact on morbid obesity. Exp Clin Endocrinol Diabetes. 2002;110:230-4.
108. Sramkova D, Kunesova M, Hainer V, Hill M, Vcelak J, Bendlova B. Is a Pro12Ala polymorphism of the PPAR-gamma2 gene related to obesity and type 2 diabetes mellitus in the Czech population? Ann N Y Acad Sci. 2002;967:265-73.
109. Zietz B, Barth N, Spiegel D, Schmitz G, Scholmerich J, Schaffler A. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male Caucasian type 2 diabetes patients. Exp Clin Endocrinol Diabetes. 2002;110:60-6.
110. Chuang LM, Hsiung CA, Chen YD, et al. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance. J Mol Med. 2001;79:656-64.
111. Ma X, Warram JH, Trischitta V, Doria A. Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab. 2002;87:4407-10.
112. Sentinelli F, Romeo S, Arca M, et al. Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes. 2002;51:860-2.
113. Pizzuti A, Argiolas A, Di Paola R, et al. An ATG repeat in the 3′-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab. 2002;87:4403-6.
114. Wang H, Chu WS, Hemphill C, Elbein SC. Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab. 2002;87:2520-4.
115. Hinney A, Antwerpen B, Geller F, et al. No evidence for involvement of the calpain-10 gene 'high-risk' haplotype combination for non-insulin-dependent diabetes mellitus in early onset obesity. Mol Genet Metab. 2002;76:152-6.
116. Daimon M, Oizumi T, Saitoh T, et al. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract. 2002;56:147-52.
117. Hoffstedt J, Naslund E, Arner P. Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells. J Clin Endocrinol Metab. 2002;87:3362-7.
118. Masuda K, Osada H, Iitsuka Y, Seki K, Sekiya S. Positive association of maternal G protein beta3 subunit 825T allele with reduced head circumference at birth. Pediatr Res. 2002;52:687-91.
119. Dzida G, Golon-Siekierska P, Puzniak A, et al. G-protein b3 subunit gene C825T polymorphism is associated with arterial hypertension in Polish patients with type 2 diabetes mellitus. Med Sci Monit. 2002;8:CR597-602.
120. Heo M, Leibel RL, Fontaine KR, et al. A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference. Int J Obes Relat Metab Disord. 2002;26:640-6.
121. Heo M, Leibel RL, Boyer BB, et al. Pooling analysis of genetic data: the association of leptin receptor (LEPR) polymorphisms with variables related to human adiposity. Genetics. 2001;159:1163-78.
122. Wauters M, Considine RV, Chagnon M, et al. Leptin levels, leptin receptor gene polymorphisms, and energy metabolism in women. Obes Res. 2002;10:394-400.
123. Furuta M, Yano Y, Ito K, et al. Relationship of the tumor necrosis factor-alpha-308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2002;56:141-5.
124. Sheu WH, Lee WJ, Lin LY, Chang RL, Chen YT. Tumor necrosis factor alpha-238 and -308 polymorphisms do not associate with insulin resistance in hypertensive subjects. Metabolism. 2001;50:1447-51.
125. Rawson ES, Nolan A, Silver K, Shuldiner AR, Poehlman ET. No effect of the Trp64Arg beta(3)-adrenoceptor gene variant on weight loss, body composition, or energy expenditure in obese, Caucasian postmenopausal women. Metabolism. 2002;51:801-5.
126. Shintani M, Ikegami H, Fujisawa T, et al. Leptin gene polymorphism is associated with hypertension independent of obesity. J Clin Endocrinol Metab. 2002;87:2909-12.
127. Miraglia Del Giudice E, Cirillo G, Nigro V, et al. Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity. Int J Obes Relat Metab Disord. 2002;26:647-51.
128. Ohshiro Y, Ueda K, Wakasaki H, et al. Sequence analysis of the pro-opiomelanocortin (POMC) gene in obese/diabetic Japanese. Int J Obes Relat Metab Disord. 2002;26:730-1.
129. Rosmond R, Ukkola O, Bouchard C, Björntorp P. Polymorphisms in exon 3 of the proopiomelanocortin gene in relation to serum leptin, salivary cortisol, and obesity in Swedish men. Metabolism. 2002;51:642-4.
130. Kostis JB, Wilson AC, Hooper WC, et al. Association of angiotensin-converting enzyme DD genotype with blood pressure sensitivity to weight loss. Am Heart J. 2002;144:625-9.
131. Rosmond R, Bouchard C, Björntorp P. A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels. J Intern Med. 2002;251:252-7.
132. Ryden M, Hoffstedt J, Eriksson P, Bringman S, Arner P. The Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis. Int J Obes Relat Metab Disord. 2001;25:1599-603.
133. Kim SH, Kim DJ, Seo IA, et al. Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Metabolism. 2002;51:833-7.
134. Tiago AD, Samani NJ, Candy GP, et al. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation. 2002;106:1483-7.
135. Nicklas BJ, Ferrell RE, Bunyard LB, Berman DM, Dennis KE, Goldberg AP. Effects of apolipoprotein E genotype on dietary-induced changes in high-density lipoprotein cholesterol in obese postmenopausal women. Metabolism. 2002;51:853-8.
136. Wilund KR, Ferrell RE, Phares DA, Goldberg AP, Hagberg JM. Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype. Metabolism. 2002;51:774-8.
137. Asai T, Ohkubo T, Katsuya T, et al. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension. 2001;38:1321-4.
138. Frittitta L, Baratta R, Spampinato D, et al. The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance. J Clin Endocrinol Metab. 2001;86:5888-91.
139. Berthier JMT, Couillard C, Prud'homme D, et al. Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men. Obes Res. 2001;9:668-75.
140. Rosmond R, Bouchard C, Björntorp P. Allelic variants in the GABA(A)alpha6 receptor subunit gene (GABRA6) is associated with abdominal obesity and cortisol secretion. Int J Obes Relat Metab Disord. 2002;26:938-41.
141. Hinney A, Hoch A, Geller F, et al. Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J Clin Endocrinol Metab. 2002;87:2716-19.
142. Rosmond R, Chagnon M, Bouchard C, Björntorp P. Polymorphism in exon 4 of (he human 3 beta-hydroxysteroid dehydrogenase type I gene (HSD3B1) and blood pressure. Biochem Biophys Res Commun. 2002;293:629-32.
143. Stumvoll M, Wahl HG, Jacob S, Rettig A, Machicao F, Haring H. Two novel prevalent polymorphisms in the hormone-sensitive lipase gene have no effect on insulin sensitivity of lipolysis and glucose disposal. J Lipid Res. 2001; 42:1782-8.
144. Blumenthal JB, Andersen RE, Mitchell BD, et al. Novel neuropeptide Y1 and Y5 receptor gene variants: associations with serum triglyceride and high-density lipoprotein cholesterol levels. Clin Genet. 2002;62:196-202.
145. Mok A, Cao H, Zinman B, et al. A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree. J Clin Endocrinol Metab. 2002;87:724-7.
146. Friedel S, Antwerpen B, Hoch A, et al. Glucose transporter 4 gene: association studies pertaining to alleles of two polymorphisms in extremely obese children and adolescents and in normal and underweight controls. Ann N Y Acad Sci. 2002;967:554-7.
147. Feral B, San Millan JL, Castello R, Moghetti P, Escobar-Morreale HF. Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism. J Clin Endocrinol Metab. 2002;87:3977-83.
148. Delplanque J, Vasseur F, Durand E, et al. Mutation screening of the urocortin gene: identification of new single nucleotide polymorphisms and association studies with obesity in French Caucasians. J Clin Endocrinol Metab. 2002;87:867-9.
149. Kiec-Wilk B, Wybranska I, Malczewska-Malec M, et al. Correlation of the -3826A >G polymorphism in the promoter of the uncoupling protein 1 gene with obesity and metabolic disorders in obese families from southern Poland. J Physiol Pharmacol. 2002;53:477-90.
150. Lindsay RS, Kobes S, Knowler WC, Bennett PH, Hanson RL. Genome-wide linkage analysis assessing parent-of-origin effects in the inheritance of type 2 diabetes and BMI in Pima Indians. Diabetes. 2001;50:2850-7.
151. Rice T, Chagnon YC, Perusse L, et al. A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: the HERITAGE Family Study. Diabetes. 2002;51:848-55.
152. Zhu X, Cooper RS, Luke A, et al. A genome-wide scan for obesity in African-Americans. Diabetes. 2002;51:541-4.
153. Feitosa MF, Borecki IB, Rich SS, et al. Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet. 2002;70:72-82.
154. Wu X, Cooper RS, Borecki I, et al. A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet. 2002;70:1247-56.
155. Stone S, Abkevich V, Hunt SC, et al. A major predisposition locus for severe obesity, at 4p15-p14. Am J Hum Genet. 2002;70:1459-68.
156. Steinle NI, Hsueh WC, Snitker S, et al. Eating behavior in the Old Order Amish: heritability analysis and a genome-wide linkage analysis. Am J Clin Nutr. 2002;75:1098-106.
157. Arya R, Blangero J, Williams K, et al. Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes. 2002;51:841-7.
158. Hunt SC, Abkevich V, Hensel CH, et al. Linkage of body mass index to chromosome 20 in Utah pedigrees. Hum Genet. 2001;109:279-85.
159. Price RA, Li W-D, Killer R. An X-chromosome scan reveals a locus for fat distribution in chromosome region Xp21-22. Diabetes. 2002;51:1989-91.
160. Clément K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392:398-401.
161. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998;19:155-7.
162. Jackson RS, Creemers JWM, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 1997;16:303-6.
163. Holder JL Jr, Butte NF, Zinn AR. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Mol Genet. 2000;9:101-8.
164. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387:903-8.
165. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet. 1998;18:213-5.
166. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab. 1999;84:3686-95.
167. Hinney A, Schmidt A, Nottebom K, et al. Several mutations in the melanocortin-4 receptor gene including a non-sense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab. 1999;84:1483-6.
168. Yeo GSH, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet. 1998;20:111-2.
169. Sina M, Hinney A, Ziegler A, et al. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am J Hum Genet. 1999;65:1501-7.
170. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet. 1998;20:113-4.
171. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest. 2000;106:253-62.
172. Gu W, Tu Z, Kleyn PW, et al. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes. 1999;48:635-9.
173. Farooqi IS, Yeo GS, Keogh JM, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest. 2000;106:271-9.
174. Mergen M, Mergen H, Ozata M, Oner R, Oner C. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab. 2001;86:3448.
175. Dubern B, Clement K, Pelloux V, et al. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte- stimulating hormone genes in severely obese children. J Pediatr. 2001;139:204-9.
176. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996;84:491-5.
177. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995;83:1263-71.
178. Naggert JK, Fricker LD, Varlamov O, et al. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet. 1995;10:135-42.
179. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32.
180. Kapeller R, Moriarty A, Strauss A, et al. Tyrosine phosphorylation of tub and its association with Src homology 2 domain-containing proteins implicate tub in intracellular signaling by insulin. J Biol Chem. 1999;274:24980-6.
181. Kleyn PW, Fan W, Kovats SG, et al. Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell. 1996;85:281-90.
182. Noben-Trauth K, Naggert JK, North MA, Nishina PM. A candidate gene for the mouse mutation tubby. Nature. 1996;380:534-8.
183. Nagle DL, McGrail SH, Vitale J, et al. The mahogany protein is a receptor involved in suppression of obesity. Nature. 1999;398:148-52.
184. Gunn TM, Miller KA, He L, et al. The mouse mahogany locus encodes a transmembrane form of human attractin. Nature. 1999;398:152-6.
185. Wilson BD, Ollmann MM, Kang L, Stoffel M, Bell GI, Barsh GS. Structure and function of ASP, the human homolog of the mouse agouti gene. Hum Mol Genet. 1995;4:223-30.
186. Shiang R, Thompson LM, Zhu YZ, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 1994;78:335-42.
187. Rousseau F, Bonaventure J, Legeai-Mallet L, et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 1994;371:252-4.
188. Bellus GA, Hefferon TW, Ortiz de Luna RI, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet. 1995;56:368-73.
189. Superti-Furga A, Eich G, Bucher HU, et al. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr. 1995;154:215-9.
190. Patten JL, Johns DR, Valle D, et al. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med. 1990;322:1412-9.
191. Fischer JA, Egert F, Werder E, Born W. An inherited mutation associated with functional deficiency of the alpha-subunit of the guanine nucleotide-binding protein Gs in pseudo- and pseudopseudohypoparathyroidism. J Clin Endocrinol Metab. 1998;83:935-8.
192. Yu D, Yu S, Schuster V, Kruse K, Clericuzio C, Weinstein L. Identification of two novel deletion mutations within the G(s)alpha gene (GNAS1) in Albright hereditary osteodystrophy. J Clin Endocrinol Metab. 1999;84:3254-9.
193. Wilson LC, Oude Luttikhuis ME, Clayton PT, Fraser WD, Trembath RC. Parental origin of Gs alpha gene mutations in Albright's hereditary osteodystrophy. J Med Genet. 1994;31:835-9.
194. Weinstein LS, Gejman PV, de Mazancourt P, American N, Spiegel AM. A heterozygous 4-bp deletion mutation in the Gs alpha gene (GNAS1) in a patient with Albright hereditary osteodystrophy. Genomics. 1992;13:1319-21.
195. Farfel Z, Iiri T, Shapira H, Roitman A, Mouallem M, Bourne HR. Pseudohypoparathyroidism, a novel mutation in the beta gamma-contact region of Gs alpha impairs receptor stimulation. J Biol Chem. 1996;271:19653-5.
196. Weinstein LS, Gejman PV, Friedman E, et al. Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A. 1990;87:8287-90.
197. Warner DR, Gejman PV, Collins RM, Weinstein LS. A novel mutation adjacent to the switch III domain of G(S alpha) in a patient with pseudohypoparathyroidism. Mol Endocrinol. 1997;11:1718-27.
198. Warner DR, Weng G, Yu S, Matalon R, Weinstein LS. A novel mutation in the switch 3 region of Gsalpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation. J Biol Chem. 1998;273:23976-83.
199. Iiri T, Herzmark P, Nakamoto JM, van Dop C, Bourne HR. Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function. Nature. 1994;371:164-8.
200. Schwindinger WF, Miric A, Zimmerman D, Levine MA. A novel Gs alpha mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenylyl cyclase. J Biol Chem. 1994;269:25387-91.
201. Aldred MA, Trembath RC. Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat. 2000;16:183-9.
202. Ahmed SF, Dixon PH, Bonthron DT, et al. GNAS1 mutational analysis in pseudohypoparathyroidism. Clin Endocrinol (Oxf). 1998;49:525-31.
203. Ishikawa Y, Tajinia T, Nakae J, et al. Two mutations of the Gsalpha gene in two Japanese patients with sporadic pseudohypoparathyroidism type Ia. J Hum Genet. 2001;46:426-30.
204. Hedeland H, Berntorp K, Arheden K, Kristoffersson U. Pseudohypoparathyroidism type I and Albright's hereditary osteodystrophy with a proximal 15q chromosomal deletion in mother and daughter. Clin Genet. 1992;42:129-34.
205. Gillessen-Kaesbach G, Demuth S, Thiele H, Theile U, Lich C, Horsthemke B. A previously unrecognised phenotype characterised by obesity, muscular hypotonia, and ability to speak in patients with Angelman syndrome caused by an imprinting defect. Eur J Hum Genet. 1999;7:638-44.
206. Stratakis CA, Lafferty A, Taymans SE, Gafni RI, Meek JM, Blancato J. Anisomastia associated with interstitial duplication of chromosome 16, mental retardation, obesity, dysmorphic facies, and digital anomalies: molecular mapping of a new syndrome by fluorescent in situ hybridization and microsatellites to 16q13 (D16S419-D16S503). J Clin Endocrinol Metab. 2000;85:3396-401.
207. Anderson J, Khan M, David W, et al. Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22. Am J Med Genet. 1999;82:161-5.
208. Peters J, Barnes R, Bennett L, Gitomer W, Bowcock A, Garg A. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat Genet. 1998;18:292-5.
209. Wertheimer E, Litvin Y, Ebstein RP, et al. Deletion of exon 3 of the insulin receptor gene in a kindred with a familial form of insulin resistance. J Clin Endocrinol Metab. 1994;78:1153-8.
210. Shimada F, Taira M, Suzuki Y, et al. Insulin-resistant diabetes associated with partial deletion of insulin-receptor gene. Lancet. 1990;335:1179-81.
211. Shimada F, Suzuki Y, Taira M, et al. Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance. Diabetologia. 1992;35:639-44.
212. Cama A, de la Luz Sierra M, Ottini L, et al. A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. J Clin Endocrinol Metab. 1991;73:894-901.
213. Kim H, Kadowaki H, Sakura H, et al. Detection of mutations in the insulin receptor gene in patients with insulin resistance by analysis of single-stranded conformational polymorphisms. Diabetologia. 1992;35:261-6.
214. Moller DE, Cohen O, Yamaguchi Y, et al. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes. 1994;43:247-55.
215. Krook A, Kumar S, Laing I, Boulton AJ, Wass JA, O'Rahilly S. Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes. 1994;43:357-68.
216. Globerman H, Karnieli E. Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans (type C insulin resistance). Int J Obes Relat Metab Disord. 1998;22:349-53.
217. Heon E, Mathers WD, Alward WL, et al. Linkage of posterior polymorphous corneal dystrophy to 20q11. Hum Mol Genet. 1995;4:485-8.
218. Kuslich CD, Kobori JA, Mohapatra G, Gregorio-King C, Donlon TA. Prader-Willi syndrome is caused by disruption of the SNRPN gene. Am J Hum Genet. 1999;64:70-6.
219. Ohta T, Gray TA, Rogan PK, et al. Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet. 1999;64:397-413.
220. Robinson WP, Bottani A, Xie YG, et al. Molecular, cytogenetic, and clinical investigations of Prader-Willi syndrome patients. Am J Hum Genet. 1991;49:1219-34.
221. Jay P, Rougeulle C, Massacrier A, et al. The human necdin gene NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat Genet. 1997;17:357-61.
222. Ming JE, Blagowidow N, Knoll JH, et al. Submicroscopic deletion in cousins with Prader-Willi syndrome causes a grandmatrilineal inheritance pattern: effects of imprinting. Am J Med Genet. 2000;92:19-24.
223. Hordijk R, Wierenga H, Scheffer H, Leegte B, Hofstra RM, Stolte-Dijkstra I. Maternal uniparental disomy for chromosome 14 in a boy with a normal karyotype. J Med Genet. 1999;36:782-5.
224. Wevrick R, Kerns JA, Francke U. Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum Mol Genet. 1994;3:1877-82.
225. Jong MT, Gray TA, Ji Y, et al. A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping anti-sense transcript in the Prader-Willi syndrome critical region. Hum Mol Genet. 1999;8:783-93.
226. Boccaccio I, Glatt-Deeley H, Watrin F, Roeckel N, Lalande M, Muscatelli F. The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region. Hum Mol Genet. 1999;8:2497-505.
227. Lee S, Kozlov S, Hernandez L, et al. Expression and imprinting of MAGEL2 suggest a role in Prader-Willi syndrome and the homologous murine imprinting phenotype. Hum Mol Genet. 2000;9:1813-9.
228. de los Santos T, Schweizer J, Rees CA, Francke U. Small evolutionarily conserved RNA, resembling C/D box small nucleolar RNA, is transcribed from PWCR1, a novel imprinted gene in the Prader-Willi deletion region, which is highly expressed in brain. Am J Hum Genet. 2000;67:1067-82.
229. Wirth J, Back E, Huttenhofer A, et al. A translocation breakpoint cluster disrupts the newly defined 3′ end of the SNURF-SNRPN transcription unit on chromosome 15. Hum Mol Genet. 2001;10:201-10.
230. Behr M, Ramsden DB, Loos U. Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbAB1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone. J Clin Endocrinol Metab. 1997;82:1081-7.
231. Bamshad M, Lin RC, Law DJ, et al. Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat Genet. 1997;16:311-5.
232. Macari F, Lautier C, Girardet A, et al. Refinement of genetic localization of the Alstrom syndrome on chromosome 2p12-13 by linkage analysis in a North African family. Hum Genet. 1998;103:658-61.
233. Collin GB, Marshall JD, Boerkoel CF, et al. Alstrom syndrome: further evidence for linkage to human chromosome 2p13. Hum Genet. 1999;105:474-9.
234. Bruford EA, Ruse R, Teague PW, et al. Linkage mapping in 29 Bardet-Biedl syndrome families confirms loci in chromosomal regions 11q13, 15q22.3-q23, and 16q21. Genomics. 1997;41:93-9.
235. Katsanis N, Lewis RA, Stockton DW, et al. Delineation of the critical interval of Bardet-Biedl syndrome 1 (BBS1) to a small region of 11q13, through linkage and haplotype analysis of 91 pedigrees. Am J Hum Genet. 1999;65:1672-9.
236. Young TL, Woods MO, Parfrey PS, Green JS, Hefferton D, Davidson WS. A founder effect in the Newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM. Am J Hum Genet. 1999;65:1680-7.
237. Kwitek-Black AE, Carmi R, Duyk GM, et al. Linkage of Bardet-Biedl syndrome to chromosome 16q and evidence for non-allelic genetic heterogeneity. Nat Genet. 1993;5:392-6.
238. Nishimura DY, Searby CC, Carmi R, et al. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet. 2001;10:865-74.
239. Young TL, Woods MO, Parfrey PS, et al. Canadian Bardet-Biedl syndrome family reduces the critical region of BBS3 (3p) and presents with a variable phenotype. Am J Med Genet. 1998;78:461-7.
240. Sheffield VC, Carmi R, Kwitek-Black A, et al. Identification of a Bardet-Biedl syndrome locus on chromosome 3 and evaluation of an efficient approach to homozygosity mapping. Hum Mol Genet. 1994;3:1331-5.
241. Beales PL, Katsanis N, Lewis RA, et al. Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci. Am J Hum Genet. 2001;68:606-16.
242. German S, Haider N, Grieshammer U, et al. The cloning and developmental expression of unconventional myosin IXA (MYO9A) a gene in the Bardet-Biedl syndrome (BBS4) region at chromosome 15q22-q23. Genomics. 1999;59:150-60.
243. Carmi R, Rokhlina T, Kwitek-Black AE, et al. Use of a DNA pooling strategy to identify a human obesity syndrome locus on chromosome 15. Hum Mol Genet. 1995;4:9-13.
244. Mykytyn K, Braun T, Carmi R, et al. Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet. 2001;28:188-91.
245. Woods M, Young T, Parfrey P, Hefferton D, Green J, Davidson W. Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: evidence for a fifth locus. Genomics. 1999;55:2-9.
246. Young TL, Penney L, Woods MO, et al. A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31. Am J Hum Genet. 1999;64:900-4.
247. Slavotinek AM, Stone EM, Mykytyn K, et al. Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet. 2000;26:15-6.
248. Katsanis N, Beales PL, Woods MO, et al. Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat Genet. 2000;26:67-70.
249. Garg A, Wilson R, Barnes R, et al. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab. 1999;84:3390-4.
250. Magre J, Delepine M, Khallouf E, et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001;28:365-70.
251. Matthijs G, Schollen E, Pardon E, et al. Mutations in PMMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome) [published erratum appears in Nat Genet. 1997;16:316]. Nat Genet. 1997;16:88-92.
252. Vuillaumier-Barrot S, Barnier A, Cuer M, Durand G, Grandchamp B, Seta N. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate- deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping. Hum Mutat. 1999;14:543-4.
253. Imtiaz F, Worthington V, Champion M, et al. Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1. J Inherit Metab Dis. 2000;23:162-74.
254. Tahvanainen E, Norio R, Karila E, et al. Cohen syndrome gene assigned to the long arm of chromosome 8 by linkage analysis. Nat Genet. 1994;7:201-4.
255. Kivitie-Kallio S, Norio R. Cohen syndrome: essential features, natural history, and heterogeneity. Am J Med Genet. 2001;102:125-35.
256. Mendonca BB, Osorio MG, Latronico AC, Estefan V, Lo LS, Arnhold IJ. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the PROP1 gene. J Clin Endocrinol Metab. 1999;84:942-5.
257. Rosenbloom AL, Almonte AS, Brown MR, Fisher DA, Baumbach L, Parks JS. Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab. 1999;84:50-7.
258. Santer R, Schneppenheim R, Dombrowski A, Gotze H, Steinmann B, Schaub J. Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome [published erratum appears in Nat Genet. 1998;18:298]. Nat Genet. 1997;17:324-6.
259. Sakamoto O, Ogawa E, Ohura T, et al. Mutation analysis of the GLUT2 gene in patients with Fanconi-Bickel syndrome. Pediatr Res. 2000;48:586-9.
260. Burwinkel B, Sanjad SA, Al-Sabban E, Al-Abbad A, Kilimann MW. A mutation in GLUT2, not in phosphorylase kinase subunits, in hepato-renal glycogenosis with Fanconi syndrome and low phosphorylase kinase activity. Hum Genet. 1999;105:240-3.
261. Akagi M, Inui K, Nakajima S, et al. Mutation analysis of two Japanese patients with Fanconi-Bickel syndrome. J Hum Genet. 2000;45:60-2.
262. Wajnrajch MP, Gertner JM, Harbison MD, Chua SC Jr, Leibel RL. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet. 1996;12:88-90.
263. Salvatori R, Hayashida CY, Aguiar-Oliveira MH, et al. Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab. 1999;84:917-23.
264. Gecz J, Baker E, Donnelly A, et al. Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Borjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient. Hum Genet. 1999;104:56-63.
265. Kubota T, Oga S, Ohashi H, Iwamoto Y, Fukushima Y. Borjeson-Forssman- Lehmann syndrome in a woman with skewed X-chromosome inactivation. Am J Med Genet. 1999;87:258-61.
266. Schwartz M, Yang HM, Niebuhr E, Rosenberg T, Page DC. Regional localization of polymorphic DNA loci on the proximal long arm of the X chromosome using deletions associated with choroideremia. Hum Genet. 1988;78:156-60.
267. Merry DE, Lesko JG, Sosnoski DM, et al. Choroideremia and deafness with stapes fixation: a contiguous gene deletion syndrome in Xq21. Am J Hum Genet. 1989;45:530-40.
268. Steinmuller R, Steinberger D, Muller U. MEHMO (mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly, obesity), a novel syndrome: assignment of disease locus to xp21.1-p22.13 [see comments]. Eur J Hum Genet. 1998;6:201-6.
269. DeLozier-Blanchet CD, Haenggeli CA, Bottani A. MEHMO, a novel syndrome: assignment of disease locus to Xp21.1-p22.13. Mental retardation, epileptic seizures, hypogonadism and genitalism, microcephaly, obesity [letter; comment]. Eur J Hum Genet. 1999;7:621-2.
270. Ahmad W, De Fusco M, ul Haque MF, et al. Linkage mapping of a new syndromic form of X-linked mental retardation, MRXS7, associated with obesity. Eur J Hum Genet. 1999;7:828-32.
271. Monaghan KG, Van Dyke DL, Feldman GL. Prader-Willi-like syndrome in a patient with an Xq23q25 duplication. Am J Med Genet. 1998;80:227-31.
272. Shashi V, Berry MN, Shoaf S, Sciote JJ, Goldstein D, Hart TC. A unique form of mental retardation with a distinctive phenotype maps to Xq26-q27 [published erratum appears in Am J Hum Genet. 2000;66:1472]. Am J Hum Genet. 2000;66:469-79.
273. Pilia G, Hughes-Benzie RM, MacKenzie A, et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet. 1996;12:241-7.
274. Hughes-Benzie RM, Pilia G, Xuan JY, et al. Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families. Am J Med Genet. 1996;66:227-34.
275. Lindsay S, Ireland M, O'Brien O, et al. Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome. J Med Genet. 1997;34:480-3.
276. Veugelers M, Vermeesch J, Watanabe K, Yamaguchi Y, Marynen P, David G. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. Genomics. 1998;53:1-11.
277. Xuan JY, Hughes-Benzie RM, MacKenzie AE. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family. J Med Genet. 1999;36:57-8.
278. Okamoto N, Yagi M, Imura K, Wada Y. A clinical and molecular study of a patient with Simpson-Golabi-Behmel syndrome. J Hum Genet. 1999;44:327-9.
279. Neri G, Gurrieri F, Zanni G, Lin A. Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome. Am J Med Genet. 1998;79:279-83.
280. Veugelers M, Cat BD, Muyldermans SY, et al. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum Mol Genet. 2000;9:1321-8.
281. Brzustowicz LM, Farrell S, Khan MB, Weksberg R. Mapping of a new SGBS locus to chromosome Xp22 in a family with a severe form of Simpson-Golabi-Behmel syndrome. Am J Hum Genet. 1999;65:779-83.
282. Wilson M, Mulley J, Gedeon A, Robinson H, Turner G. New X-linked syndrome of mental retardation, gynecomastia, and obesity is linked to DXS255. Am J Med Genet. 1991;40:406-13.
283. Gedeon A, Mulley J, Turner G. Gene localisation for Wilson-Turner syndrome (WTS:MIM 309585). Am J Med Genet. 1996;64:80-1.
284. Good DJ, Porter FD, Mahon KA, Parlow AF, Westphal H, Kirsch IR. Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene. Nat Genet. 1997;15:397-401.
285. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature. 1996;382:622-6.
286. Masuzaki H, Paterson J, Shinyania H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001;294:2166-70.
287. Yamada M, Miyakawa T, Duttaroy A, et al. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature. 2001;410:207-12.
288. Reizes O, Lincecum J, Wang Z, et al. Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell. 2001;106:105-16.
289. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology. 2000;141:4295-308.
290. Hirsch E, Irikura VM, Paul SM, Hirsh D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci U S A. 1996;93:11008-13.
291. Masaki T, Yoshimatsu H, Chiba S, Watanabe T, Sakata T. Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. Diabetes. 2001;50:385-91.
292. Ma YH, Hu JH, Zhou XG, et al. Transgenic mice overexpressing gamma-aminobutyric acid transporter subtype I develop obesity. Cell Res. 2000;10:303-10.
293. Fain JN, Del Mar NA, Meade CA, Reiner A, Goldowitz D. Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation. Hum Mol Genet. 2001;10:145-52.
294. Zhou QY, Palmiter RD. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell. 1995;83:1197-209.
295. Hahm S, Mizuno TM, Wu TJ, et al. Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron. 1999;23:537-48.
296. Tsukiyama-Kohara K, Poulin F, Kohara M, et al. Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med. 2001;7:1128-32.
297. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996;274:1377-9.
298. Smith SJ, Cases S, Jensen DR, et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet. 2000;25:87-90.
299. Kozak LP, Kozak UC, Clarke GT. Abnormal brown and white fat development in transgenic mice overexpressing glycerol 3-phosphate dehydrogenase. Genes Dev. 1991;5:2256-64.
300. Anand A, Chada K. In vivo modulation of Hmgic reduces obesity. Nat Genet. 2000;24:377-80.
301. Elchebly M, Fayette P, Michaliszyn E, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999;283:1544-8.
302. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature. 1998;396:670-4.
303. Ludwig DS, Tritos NA, Mastaitis JW, et al. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest. 2001;107:379-86.
304. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 2001;291:2613-6.
305. Moitra J, Mason MM, Olive M, et al. Life without white fat: a transgenic mouse. Genes Dev. 1998;12:3168-81.
306. Jones ME, Thorburn AW, Britt KL, et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A. 2000;97:12735-40.
307. Martinez-Botas J, Anderson JB, Tessier D, et al. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet. 2000;26:474-9.
308. Tansey JT, Sztalryd C, Gruia-Gray J, et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A. 2001;98:6494-9.
309. Beattie JH, Wood AM, Newman AM, et al. Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci U S A. 1998;95:358-63.
310. Shimomura I, Hammer RE, Richardson JA, et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 1998;12:3182-94.
311. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest. 1996;98:1575-84.
312. Udy GB, Towers RP, Snell RG, et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A. 1997;94:7239-44.
313. Hara J, Beuckmann CT, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 2001;30:345-54.
314. Ueno N, Inui A, Iwamoto M, et al. Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology. 1999;117:1427-32.
315. Murray I, Havel PJ, Sniderman AD, Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology. 2000;141:1041-9.
316. Dong ZM, Gutierrez-Ramos JC, Coxon A, Mayadas TN, Wagner DD. A new class of obesity genes encodes leukocyte adhesion receptors. Proc Natl Acad Sci U S A. 1997;94:7526-30.
317. Wang ND, Finegold MJ, Bradley A, et al. Impaired energy homeostasis in C/EBP alpha knockout mice. Science. 1995;269:1108-12.
318. Clouthier DE, Comerford SA, Hammer RE. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-betal transgenic mice. J Clin Invest. 1997;100:2697-713.
319. Jong MC, Voshol PJ, Muurling M, et al. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes. 2001;50:2779-85.
320. Cai A, Hyde JF. The human growth hormone-releasing hormone transgenic mouse as a model of modest obesity: differential changes in leptin receptor (OBR) gene expression in the anterior pituitary and hypothalamus after fasting and OBR localization in somatotrophs. Endocrinology. 1999;140:3609-14.
321. Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 1997;16:7432-43.
322. Ohki-Hamazaki H, Watase K, Yamamoto K, et al. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature. 1997;390:165-9.
323. Robinson SW, Dinulescu DM, Cone RD. Genetic models of obesity and energy balance in the mouse. Annu Rev Genet. 2000;34:687-745.
324. Brockmann GA, Bevova MR. Using mouse models to dissect the genetics of obesity. Trends Genet. 2002;18:367-76.
325. Warden CH, Fisler JS, Shoemaker SM, et al. Identification of four chromosomal loci determining obesity in a multifactorial mouse model. J Clin Invest. 1995;95:1545-52.
326. Lembertas AV, Pérusse L, Chagnon YC, et al. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest. 1997;100:1240-7.
327. Mehrabian M, Wen P, Fisler J, Davis R, Lusis A. Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. J Clin Invest. 1998;101:2485-96.
328. West DB, Waguespack J, York B, Goudey-Lebevre J, Price RA. Genetics of dietary obesity in AKR/J X SWR/J mice: segregation of the trait and identification of a linked locus on chromosome 4. Mamm Genome. 1994;5:546-52.
329. West DB, Goudey-Lefevre J, York B, Truett GE. Dietary obesity linked to genetic loci on chromosomes 9 and 15 in a polygenic mouse model. J Clin Invest. 1994;94:1410-6.
330. Kluge R, Giesen K, Bahrenberg G, Plum L, Ortlepp JR, Joost HG. Quantitative trait loci for obesity and insulin resistance (Nob1, Nob2) and their interaction with the leptin receptor allele (LeprA720T/T1044I) in New Zealand obese mice. Diabetologia. 2000;43:1565-72.
331. Reifsnyder PC, Churchill G, Leiter EH. Maternal environment and genotype interact to establish diabesity in mice. Genome Res. 2000;10:1568-78.
332. Dragani TA, Zeng ZB, Canzian F, et al. Mapping of body weight loci on mouse chromosome X. Mamm Genome. 1995;6:778-81.
333. Rance KA, Hill WG, Keightley PD. Mapping quantitative trait loci for body weight on the X chromosome in mice. I. Analysis of a reciprocal F2 population. Genet Res. 1997;70:117-24.
334. Brockmann G, Timtchenko D, Das P, et al. Detection of QTL for body weight and body fat content in mice using genetic markers. J Anim Breed Genet. 1996;113:373-9.
335. Brockmann GA, Haley CS, Renne U, Knott SA, Schwerin M. Quantitative trait loci affecting body weight and fatness from a mouse line selected for extreme high growth. Genetics. 1998;150:369-81.
336. Brockmann GA, Kratzsch J, Haley CS, Renne U, Schwerin M, Karle S. Single QTL effects, epistasis, and pleiotropy account for two-thirds of the phenotypic F(2) variance of growth and obesity in DU6i X DBA/2 mice. Genome Res. 2000;10:1941-57.
337. Taylor BA, Phillips SJ. Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. Genomics. 1996;34:389-98.
338. Taylor BA, Phillips SJ. Obesity QTLs on mouse chromosome 2 and 17. Genomics. 1997;43:249-57.
339. Taylor BA, Wnek C, Schroeder D, Phillips SJ. Multiple obesity QTLs identified in an intercross between the NZO (New Zealand obese) and the SM (small) mouse strains. Mamm Genome. 2001;12:95-103.
340. Hirayama I, Yi Z, Izuini S, et al. Genetic analysis of obese diabetes in the TSOD mouse. Diabetes. 1999;48:1183-91.
341. Pomp D. Genetic dissection of obesity in polygenic animal models. Behav Genet. 1997;27:285-306.
342. Taylor BA, Tarantino LM, Phillips SJ. Gender-influenced obesity QTLs identified in a cross involving the KK type II diabetes-prone mouse strain. Mamm Genome. 1999;10:963-8.
343. Suto J, Matsuura S, Imamura K, Yamanaka H, Sekikawa K. Genetics of
344. Corva PM, Horvat S, Medrano JF. Quantitative trait loci affecting growth in high growth (hg) mice. Mamm Genome. 2001;12:284-90.
345. Moody DE, Pomp D, Nielsen MK, Van Vleck LD. Identification of quantitative trait loci influencing traits related to energy balance in selection and inbred lines of mice. Genetics. 1999;152:699-711.
346. Keightley PD, Hardge T, May L, Bulfield G. A genetic map of quantitative trait loci for body weight in the mouse. Genetics. 1996;142:227-35.
347. Keightley PD, Morris KH, Ishikavva A, Falconer VM, Oliver F. Test of candidate gene-quantitative trait locus association applied to fatness in mice. Heredity. 1998;81:630-7.
348. Ishikawa A, Matsuda Y, Namikawa T. Detection of quantitative trait loci for body weight at 10 weeks from Philippine wild mice. Mamm Genome. 2000;11:824-30.
349. Collins AC, Martin ICA, Kirkpatrick BW. Growth quantitative trait loci (QTL) on mouse Chromosome 10 in a Quackenbush-Swiss X C57BL/6J backcross. Mamm Genome. 1993;4:454-8.
350. Vaughn TT, Pletscher LS, Peripato A, et al. Mapping quantitative trait loci for murine growth: a closer look at genetic architecture. Genet Res. 1999;74:313-22.
351. Cheverud JM, Routman EJ, Duarte FA, van Swinderen B, Cothran K, Perel C. Quantitative trait loci for murine growth. Genetics. 1996;142:1305-19.
352. Cheverud JM, Vaughn TT, Pletscher LS, et al. Genetic architecture of adiposity in the cross of LG/J and SM/J inbred mice. Mamm Genome. 2001;12:3-12.
353. Ueda H, Ikegami H, Kawaguchi Y, et al. Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. Diabetes. 1999;48:1168-74.
354. Horvat S, Bunger L, Falconer V, et al. Mapping of obesity QTLs in a cross between mouse lines divergently selected on fat content. Mamm Genome. 2000;11:2-7.
355. fa associated with variability in insulin production and susceptibility to NIDDM. Genomics. 1997;41:332-44.
356. Gauguier D, Froguel P, Parent V, et al. Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. Nat Genet. 1996;12:38-43.
357. Galli J, Li LS, Glaser A, et al. Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat Genet. 1996;12:31-7.
358. Kanemoto N, Hishigaki H, Miyakita A, et al. Genetic dissection of "OLETF", a rat model for non-insulin-dependent diabetes mellitus. Mamm Genome. 1998;9:419-25.
359. Watanabe T, Okuno S, Oga K, et al. Genetic dissection of "OLETF," a rat model for non-insulin-dependent diabetes mellitus: quantitative trait locus analysis of (OLETF X BN) X OLETF. Genomics. 1999;58:233-9.
360. Ogino T, Wei S, Wei K, et al. Genetic evidence for obesity loci involved in the regulation of body fat distribution in obese type 2 diabetes rat, OLETF. Genomics. 2000;70:19-25.
361. Kato N, Hyne G, Bihoreau MT, Gauguier D, Lathrop GM, Rapp JP. Complete genome searches for quantitative trait loci controlling blood pressure and related traits in four segregating populations derived from Dahl hypertensive rats. Mamm Genome. 1999;10:259-65.
362. Kovacs P, Kloting I. Mapping of quantitative trait loci for body weight on chromosomes 1 and 4 in the rat. Biochem Mol Biol Int. 1998;44:399-405.
363. Kloting I, Kovacs P, van den Brandt J. Quantitative trait loci for body weight, blood pressure, blood glucose, and serum lipids: linkage analysis with wild rats (Rattus norvegicus). Biochem Biophys Res Commun. 2001;284:1126-33.
364. Kovacs P, Voigt B, Berg S, Vogt L, Kloting I. WOK.1W rats. A potential animal model of the insulin resistance syndrome. Ann N Y Acad Sci. 1997;827:94-9.
365. Kloting I, Kovacs P, van den Brandt J. Sex-specific and sex-independent quantitative trait loci for facets of the metabolic syndrome in WOKW rats. Biochem Biophys Res Commun. 2001;284:150-6.
366. Anderson L, Haley CS, Ellegren H, et al. Genetic mapping of quantitative trait loci for growth and fatness in pigs. Science. 1994;263:1771-4.
367. Knott SA, Marklund L, Haley CS, et al. Multiple marker mapping of quantitative trait loci in a cross between outbred wild boar and large white pigs. Genetics. 1998;149:1069-80.
368. Marklund L, Nystrom PE, Stern S, Andersson-Eklund L, Andersson L. Confirmed quantitative trait loci for fatness and growth on pig chromosome 4. Heredity. 1999;82:134-41.
369. Perez-Enciso M, Clop A, Noguera JL, et al. A QTL on pig chromosome 4 affects fatty acid metabolism: evidence from an Iberian by Landrace intercross. J Anim Sci. 2000;78:2525-31.
370. Jeon JT, Carlborg O, Tornsten A, et al. A paternally expressed QTL affecting skeletal and cardiac muscle mass in pigs maps to the IGF2 locus. Nat Genet. 1999;21:157-8.
371. Nezer C, Moreau L, Brouwers B, et al. An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat Genet. 1999;21:155-6.
372. Walling GA, Archibald AL, Cattermole JA, et al. Mapping of quantitative trait loci on porcine chromosome 4. Anim Genet. 1998;29:415-24.
373. Bidanel JP, Milan D, Iannuccelli N, et al. Detection of quantitative trait loci for growth and fatness in pigs. Genet Sel Evol. 2001;33:289-309.
374. Rohrer GA. Identification of quantitative trait loci affecting birth characters and accumulation of backfat and weight in a Meishan-White Composite resource population. J Anim Sci. 2000;78:2547-53.
375. Rothschild MF, Liu HC, Tuggle CK, Yu TP, Wang L. Analysis of pig chromosome 7 genetic markers for growth and carcass performance traits. J Anim Breed Genet. 1995;112:341-8.
376. Wang L, Yu TP, Tuggle CK, Liu HC, Rothschild MF. A directed search for quantitative trait loci on chromosomes 4 and 7 in pigs. J Anim Sci. 1998;76:2560-7.
377. Yu T, Wang L, Tuggle C, Rothschild M. Mapping genes for fatness and growth on pig chromosome 13: a search in the region close to the pig PIT1 gene. J Anim Breed Genet. 1999;116:269-80.
378. de Koning DJ, Janss LL, Rattink AP, et al. Detection of quantitative trait loci for backfat thickness and intramuscular fat content in pigs (Sus scrofa). Genetics. 1999;152:1679-90.
379. Rattink AP, De Koning DJ, Faivre M, Harlizius B, van Arendonk JA, Groenen MA. Fine mapping and imprinting analysis for fatness trait QTLs in pigs. Mamm Genome. 2000;11:656-61.
380. de Koning DJ, Rattink AP, Harlizius B, van Arendonk JA, Brascamp EW, Groenen MA. Genome-wide scan for body composition in pigs reveals important role of imprinting. Proc Natl Acad Sci U S A. 2000;97:7947-50.
381. Harlizius B, Rattink A, de KD, et al. The X chromosome harbors quantitative trait loci for backfat thickness and intra-muscular fat content in pigs. Mamm Genome. 2000;11:800-2.
382. Rohrer GA, Keele JW. Identification of quantitative trait loci affecting carcass composition in swine. I. Fat deposition traits. J Anim Sci. 1998;76:2247-54.
383. Malek M, Dekkers JC, Lee HK, et al. A molecular genome scan analysis to identify chromosomal regions influencing economic traits in the pig. II. Meat and muscle composition. Mamm Genome. 2001;12:637-45.
384. Fernandez-Real JM, Vendrell J, Ricart W, et al. Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care. 2000;23:831-7.
385. Nishigori H, Tomura H, Tonooka N, et al. Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc Natl Acad Sci U S A. 2001;98:575-80.
386. Thompson DB, Ravussin E, Bennett PH, Bogardus C. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet. 1997;6:675-9.
387. Chagnon YC, Chung WK, Pérusse L, Chagnon M, Leibel RL, Bouchard C. Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study. Int J Obes Relat Metab Disord. 1999;23:278-86.
388. Roth H, Korn T, Rosenkranz K, et al. Transmission disequilibrium and sequence variants at the leptin receptor gene in extremely obese German children and adolescents. Hum Genet. 1998;103:540-6.
389. Chagnon YC, Wilmore JH, Borecki IB, et al. Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab. 2000;85:29-34.
390. Rosmond R, Chagnon YC, Holm G, et al. Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab. 2000;85:3126-31.
391. Wauters M, Mertens I, Chagnon M, et al. Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obes Relat Metab Disord. 2001;25:714-20.
392. Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klimis-Zacas D, Mantzoros CS. The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab. 2001;86:4434-9.
393. Mammes O, Aubert R, Betoulle D, et al. LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women. Eur J Clin Invest. 2001;31:398-404.
394. Quinton ND, Lee AJ, Ross RJ, Eastell R, Blakemore AI. A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet. 2001;108:233-6.
395. Vohl MC, Dionne FT, Pérusse L, Dériaz O, Chagnon M, Bouchard C. Relation between BgIII polymorphism in 3 beta-hydroxysteroid dehydrogenase gene and adipose-tissue distribution in human. Obes Res. 1994;2:444-9.
396. Hegele RA, Cao H, Huff MW, Anderson CM. LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration. J Clin Endocrinol Metab. 2000;85:3089-93.
397. Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJ, Anderson CM. Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians. Physiol Genomics. 2000;3:39-44.
398. Hegele RA, Anderson CM, Wang J, Jones DC, Cao H. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res. 2000;10:652-8.
399. Hegele RA, Huff MW, Young TK. Common genomic variation in LMNA modulates indexes of obesity in Inuit. J Clin Endocrinol Metab. 2001;86:2747-51.
400. Dériaz O, Dionne F, Pérusse L, et al. DNA variation in the genes of the Na,K-adenosine triphosphatase and the its relation with resting metabolic rate, respiratory quotient, and body fat. J Clin Invest. 1994;93:838-43.
401. Katzmarzyk PT, Rankinen T, Pérusse L, et al. Linkage and association of the sodium potassium-adenosine triphosphatase alpha2 and beta1 genes with respiratory quotient and resting metabolic rate in the Quebec Family Study. J Clin Endocrinol Metab. 1999;84:2093-7.
402. van 't Hooft FM, Ruotolo G, Boquist S, de Faire U, Eggertsen G, Hamsten A. Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation. 2001;104:1223-8.
403. Regele RA, Brunt JH, Connelly PW. Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation. 1995;92:1089-93.
404. Rankinen T, Gagnon J, Pérusse L, et al. Body fat, resting and exercise blood pressure and the angiotensinogen M235T polymorphism: the HERITAGE family study. Obes Res. 1999;7:423-30.
405. Lucarini N, Finocchi G, Gloria-Bottini F, et al. A possible genetic component of obesity in childhood. Observations on acid phosphatase polymorphism. Experientia. 1990;46:90-1.
406. Lucarini N, Antonacci E, Bottini N, Gloria-Bottini F. Low-molecular-weight acid phosphatase (ACP1), obesity,and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus. Hum Biol. 1997;69:509-15.
407. Rajput-Williams J, Wallis SC, Yarnell J, et al. Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet. 1988;2:1442-6.
408. Saha N, Tay JSH, Heng CK, Humphries SE. DNA polymorphisms of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore. Clin Genet. 1993;44:113-20.
409. Pouliot MC, Després JP, Dionne FT, et al. Apo B-100 gene EcoR1 polymorphism. Relations to plasma lipoprotein changes associated with abdominal visceral obesity. Arterioscler Thromb. 1994;14:527-33.
410. Hixson J, Almasy L, Cole S, et al. Normal variation in leptin levels is associated with polymorphisms in the proopiomelanocortin gene, POMC. J Clin Endocrinol Metab. 1999;84:3187-91.
411. del Giudice EM, Cirillo G, Santoro N, et al. Molecular screening of the proopiomelanocortin (POMC) gene in Italian obese children: report of three new mutations. Int J Obes Relat Metab Disord. 2001;25:61-7.
412. Heinonen P, Koulu M, Pesonen U, et al. Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab. 1999;84:2429-33.
413. Lei H, Coresh J, Shuldiner A, Boerwinkle E, Brancati F. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans - the Atherosclerosis Risk in Communities Study. Diabetes. 1999;48:1868-72.
414. Krempler F, Hell E, Winkler C, Breban D, Patsch W. Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1. Arterioscler Thromb Vasc Biol. 1998;18:1686-90.
415. Ukkola O, Ravussin E, Jacobson P, et al. Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab. 2001;86:3996-9.
416. Meirhaeghe A, Fajas L, Helbecque N, et al. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet. 1998;7:435-40.
417. Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20:284-7.
418. Ek J, Urhammer SA, Sorensen TI, Andersen T, Auwerx J, Pedersen O. Homozygosity of the Pro12Ala variant of the peroxisome proliferation- activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia. 1999;42:892-5.
419. Ristow M, Müller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med. 1998;339:953-9.
420. Valve R, Sirenius K, Miettinen R, et al. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab. 1999;84:3708-12.
421. Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Colantuoni V, Riccardi G. Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma2 (PPARgamma2) and severe obesity: a case-control study. Int J Obes Relat Metab Disord. 2000;24:1195-9.
422. Cole SA, Mitchell BD, Hsueh WC, et al. The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans. Int J Obes Relat Metab Disord. 2000;24:522-4.
423. Meirhaeghe A, Fajas L, Helbecque N, et al. Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord. 2000;24:195-9.
424. Nicklas BJ, van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes. 2001;50:2172-6.
425. Hasstedt SJ, Ren QF, Teng K, Elbein SC. Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds. J Clin Endocrinol Metab. 2001;86:536-41.
426. Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MI. Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia. 2001;44:925-6.
427. Vijayaraghavan S, Hitman GA, Kopelman PG. Apolipoprotein D polymorphism: a genetic marker of obesity and hyperinsulinemia. J Clin Endocrinol Metab. 1994;79:568-70.
428. Funakoshi A, Miyasaka K, Matsumoto H, et al. Gene structure of human cholecystokinin (CCK) type-A receptor: body fat content is related to CCK type-A receptor gene promoter polymorphism. FEBS Lett. 2000;466:264-6.
429. Yamada K, Yuan X, Ishiyama S, et al. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia. 1997;40:706-10.
430. Hegele RA, Harris SB, Hanley AJG, Sadikian S, Connelly PW, Zinman B. Genetic variation of intestinal fatty acid binding protein associated with variation in body mass in Aboriginal Canadians. J Clin Endocrinol Metab. 1996;81:4334-7.
431. Oppert JM, Vohl MC, Chagnon M, et al. DNA polymorphism in the uncoupling protein (UCP) gene and human body fat. Int J Obes Relat Metab Disord. 1994;18:526-31.
432. Fumeron F, Durack-Bown I, Betoulle D, et al. Polymorphisms of uncoupling protein (UCP) and beta 3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int J Obes Relat Metab Disord. 1996;20:1051-4.
433. Kogure A, Yoshida T, Sakane N, Umekawa T, Takakura Y, Kondo M. Synergic effect of polymorphisms in uncoupling protein 1 and beta3- adrenergic receptor genes on weight loss in obese Japanese. Diabetologia. 1998;41:1399.
434. Heilbronn LK, Kind KL, Pancewicz E, Morris AM, Noakes M, Clifton PM. Association of -3826 G variant in uncoupling protein-1 with increased BMI in overweight Australian women. Diabetologia. 2000;43:242-4.
435. Jenkinson CP, Cray K, Walder K, Herzog H, Hanson, Ravussin E. Novel polymorphisms in the neuropeptide-Y Y5 receptor associated with obesity in Pima Indians. Int J Obes Relat Metab Disord. 2000;24:580-4.
436. Challis BG, Yeo GS, Farooqi IS, et al. The CART gene and human obesity: mutational analysis and population genetics. Diabetes. 2000;49:872-5.
437. Buemann B, Vohl MC, Chagnon M, et al. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res. 1997;5:186-92.
438. Rosmond R, Chagnon YC, Holm G, et al. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res. 2000;8:211-8.
439. Ukkola O, Perusse L, Chagnon YC, Despres JP, Bouchard C. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Quebec Family Study. Int J Obes Relat Metab Disord. 2001;25:1332-9.
440. Ukkola O, Rosmond R, Tremblay A, Bouchard C. Glucocorticoid receptor BclI variant is associated with an increased atherogenic profile in response to long-term overfeeding. Atherosclerosis. 2001;157:221-4.
441. Dobson MG, Redfern CP, Unwin N, Weaver JU. The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab. 2001;86:2270-4.
442. Large V, Hellstrom L, Reynisdottir S, et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest. 1997;100:3005-13.
443. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K. Association of polymorphisms in the beta 2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia. 1999;42:98-101.
444. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P. Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet. 1999;353:896.
445. Yamada K, Ishiyama-Shigemoto S, Ichikawa F, et al. Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab. 1999;84:1754-7.
446. Mori Y, Kim-Motoyama H, Ito Y, et al. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun. 1999;258:138-40.
447. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P. Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord. 2000;24:382-7.
448. Ukkola O, Rankinen T, Weisnagel SJ, et al. Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism. 2000;49:1063-70.
449. Ehrenborg E, Skogsberg J, Ruotolo G, et al. The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins. J Intern Med. 2000;247:651-6.
450. Rosmond R, Ukkola O, Chagnon M, Bouchard C, Björntorp P. Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med. 2000;248:239-44.
451. Hoffstedt J, Iliadou A, Pedersen NL, Schalling M, Amer P. The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br J Pharmacol. 2001;133:708-12.
452. van Rossum CT, Hoebee B, Seidell JC, et al. Genetic factors as predictors of weight gain in young adult Dutch men and women. Int J Obes Relat Metab Disord. 2002;26:517-28.
453. Ukkola O, Tremblay A, Bouchard C. Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding. Int J Obes Relat Metab Disord. 2001;25:1604-8.
454. Fernandez-Real JM, Gutierrez C, Ricart W, et al. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes. 1997;46:1468-72.
455. Norman RA, Bogardus C, Ravussin E. Linkage between obesity and a marker near the tumor necrosis factor-A locus in Pima Indians. J Clin Invest. 1995;96:158-62.
456. Herrmann S, Ricard S, Nicaud V, et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest. 1998;28:59-66.
457. Pausova Z, Deslauriers B, Gaudet D, et al. Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension. 2000;36:14-9.
458. Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Ryden M, Arner P. Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia. 2000;43:117-20.
459. Kamizono S, Yaniada K, Seki N, et al. Susceptible locus for obese type 2 diabetes mellitus in the 5′-flanking region of the tumor necrosis factor-alpha gene. Tissue Antigens. 2000;55:449-52.
460. Brand E, Schorr U, Kunz I, et al. Tumor necrosis factor-alpha-308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord. 2001;25:581-5.
461. Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID. Association of the TNF-alpha-308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res. 2002;10:401-7.
462. Chouchane L, Danguir J, Beji C, et al. Genetic variation in the stress protein hsp70-2 gene is highly associated with obesity. Int J Obes Relat Metab Disord. 2001;25:462-6.
463. Levitan RD, Kaplan AS, Masellis M, et al. Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biol Psychiatry. 2001;50:640-3.
464. Speer G, Cseh K, Winkler G, et al. Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol. 2001;144:385-9.
465. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998;19:268-70.
466. Karvonen MK, Koulu M, Pesonen U, et al. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children. J Clin Endocrinol Metab. 2000;85:1455-60.
467. Bray MS, Boerwinkle E, Hanis CL. Sequence variation within the neuropeptide Y gene and obesity in Mexican Americans. Obes Res. 2000;8:219-26.
468. Busch C, Ramdath D, Ramsewak S, Hegele R. Association of PON2 variation with birth weight in Trinidadian neonates of South Asian ancestry. Pharmacogenetics. 1999;9:351-6.
469. Oksanen L, Ohman M, Heiman M, et al. Markers for the gene ob and serum leptin levels in human morbid obesity. Hum Genet. 1997;99:559-64.
470. Shintani M, Ikegami H, Yamato E, et al. A novel microsatellite polymorphism in the human OB gene: a highly polymorphic marker for linkage analysis. Diabetologia. 1996;39:1398-401.
471. Hager J, Clement K, Francke S, et al. A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels. Int J Obes Relat Metab Disord. 1998;22:200-5.
472. Mammes O, Betoulle D, Aubert R, et al. Novel polymorphisms in the 5′ region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes. 1998;47:487-9.
473. Butler MG, Hedges L, Hovis CL, Feurer ID. Genetic variants of the human obesity (OB) gene in subjects with and without Prader-Willi syndrome: comparison with body mass index and weight. Clin Genet. 1998;54:385-93.
474. Li WD, Reed DR, Lee JH, et al. Sequence variants in the 5′ flanking region of the leptin gene are associated with obesity in women. Ann Hum Genet. 1999;63:227-34.
475. Le Stunff, C, Le Bihan C, Schork NJ, Bougneres P. A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes. 2000;49:2196-200.
476. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F. Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metabl Disord. 1995;19:270-4.
477. Garenc C, Perusse L, Bergeron J, et al. Evidence of LPL gene-exercise interaction for body fat and LPL activity: the HERITAGE Family Study. J Appl Physiol. 2001;91:1334-40.
478. Corella D, Guillen M, Portoles O, et al. Gender specific associations of the Trp64Arg mutation in the beta3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation. J Intern Med. 2001;250:348-60.
479. Nagase T, Aoki A, Yamamoto M, et al. Lack of association between the Trp64 Arg mutation in the beta 3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocrinol Metab. 1997;82:1284-7.
480. Clément K, Vaisse C, Manning BSJ, et al. Genetic variation in the B3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med. 1995;333:352-4.
481. Widén E, Lehto M, Kannine T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 1995;333:348-51.
482. Kadowaki H, Yasuda K, Iwamoto K, et al. A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun. 1995;215:555-60.
483. Urhammer SA, Clausen JO, Hansen T, Pedersen O. Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the Beta 3-adrenergic receptor gene. Diabetes. 1996;45:1115-20.
484. Fujisawa T, Ikegami H, Yamato E, et al. Association of Trp64Arg mutation of the beta 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia. 1996;39:349-52.
485. Oksanen L, Mustajoki P, Kaprio J, et al. Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity. Int J Obes Relat Metab Disord. 1996;20:1055-61.
486. Sakane N, Yoshida T, Umekawa T, Kondo M, Sakai Y, Takahashi T. Beta 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia. 1997;40:200-4.
487. Kini-Motoyama H, Yasuda K, Yamaguchi T, et al. A mutation of the beta 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia. 1997;40:469-72.
488. Higashi K, Ishikawa T, Ito T, Yonemura A, Shige H, Nakamura H. Association of a genetic variation in the beta 3-adrenergic receptor gene with coronary heart disease among Japanese. Biochem Biophys Res Commun. 1997;232:728-30.
489. Jeyasingam C, Bryson J, Caterson I, Yue D, Donnelly R. Expression of the beta3-adrenoceptor gene polymorphism (Trp64Arg) in obese diabetic and non-diabetic subjects. Clin Exp Pharmacol Physiol. 1997;24:733-5.
490. McFarlane-Anderson N, Bennett F, Wilks R, et al. The Trp64Arg mutation of the beta(3)-adrenergic receptor is associated with hyperglycemia and current body mass index in Jamaican women. Metabolism. 1998;47:617-21.
491. Mitchell B, Blangero J, Comuzzie A, et al. A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest. 1998;101:584-7.
492. Shima Y, Tsukada T, Nakanishi K, Ohta H. Association of the Trp64Arg mutation of the beta(3)-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects. Clin Chim Acta. 1998;274:167-76.
493. Hoffstedt J, Poirier O, Thorne A, et al. Polymorphism of the human beta(3)-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes. 1999;48:203-5.
494. Festa A, Krugluger W, Shnawa N, Hopmeier P, Haffner SM, Schernthaner G. Trp64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus. J Clin Endocrinol Metab. 1999;84:1695-9.
495. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, et al. Relation of beta3-adrenergic receptor gene mutation to total body fat but not percent body fat and insulin levels in Thais. Metabolism. 1999;48:564-7.
496. Endo K, Yanagi H, Hirano C, Hamaguchi H, Tsuchiya S, Tomura S. Association of Trp64Arg polymorphism of the beta3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity. Int J Obes Relat Metab Disord. 2000;24:443-9.
497. Thomas GN, Tomlinson B, Chan JC, Young RP, Critchley JA. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord. 2000;24:545-51.
498. Oizumi T, Daimon M, Saitoh T, et al. Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care. 2001;24:1579-83.
499. Strazzullo P, Iacone R, Siani A, et al. Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens. 2001;19:399-406.
500. Wolford J, Bogardus C, Prochazka M. Polymorphism in the 3′ untranslated region of MTG8 is associated with obesity in Pima Indian males. Biochem Biophys Res Commun. 1998;246:624-6.
501. Lin WH, Chiu KC, Chang HM, Lee KC, Tai TY, Chuang LM. Molecular scanning of the human sorbin and SH3-domain-containing-1 (SORBS1) gene: positive association of the T228A polymorphism with obesity and type 2 diabetes. Hum Mol Genet. 2001;10:1753-60.
502. Oppert JM, Tourville J, Chagnon M, et al. DNA polymorphisms in alpha 2- and beta 2-adrenoceptor genes and regional fat distribution in humans: association and linkage studies. Obes Res. 1995;3:249-55.
503. Hani EH, Clement K, Velho G, et al. Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians. Diabetes. 1997;46:688-94.
504. O'Dell SD, Miller GJ, Cooper JA, et al. Apa1 polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord. 1997;21:822-5.
505. Dunger DB, Ong KKL, Huxtable SJ, et al. Association of the INS VNTR with size at birth. Nat Genet. 1998;19:98-100.
506. Weaver JU, Kopelman PG, Hitman GA. Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5′ flanking region of the human insulin gene. Enr J Clin Invest. 1992;22:265-70.
507. O'Dell SD, Bujac SR, Miller GJ, Day IN. Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity. Eur J Hum Genet. 1999;7:821-7.
508. Le Stunff C, Fallin D, Bougneres P. Paternal transmission of the very common class I INS VNTR alleles predisposes to childhood obesity. Nat Genet. 2001;29:96-9.
509. Walder K, Norman R, Hanson R, et al. Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism obesity in Pima Indians. Hum Mol Genet. 1998;7:1431-5.
510. Cassell PG, Neverova M, Janmohamed S, et al. An uncoupling protein 2 gene variant is associated with a raised body mass index but not type II diabetes. Diabetologia. 1999;42:688-92.
511. Astrup A, Toubro S, Dalgaard LT, Urhammer SA, Sorensen TIA, Pedersen O. Impact of the v/v 55 polymorphism of the uncoupling protein 2 gene on 24-h energy expenditure and substrate oxidation. Int J Obes Relat Metab Disord. 1999;23:1030-4.
512. Yanovski JA, Diament AL, Sovik KN, et al. Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, white, and Asian children. Am J Clin Nutr. 2000;71:1405-20.
513. Evans D, Minouchehr S, Hagemann G, et al. Frequency of and interaction between polymorphisms in the beta3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans. Int J Obes Relat Metab Disord. 2000;24:1239-45.
514. Nordfors L, Heimburger O, Lonnqvist F, et al. Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int. 2000;57:1713-9.
515. Esterbauer H, Schneitier C, Oberkofler H, et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet. 2001;28:178-83.
516. Evans D, Wolf AM, Nellessen U, et al. Association between polymorphisms in candidate genes and morbid obesity. Int J Obes Relat Metab Disord. 2001;25:S19-21.
517. Argyropoulos G, Brown AM, Willi SM, et al. Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest. 1998;102:1345-51.
518. Otabe S, Clement K, Dubois S, et al. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes. 1999;48:206-8.
519. Otabe S, Clement K, Dina C, et al. A genetic variation in the 5′ flanking region of the UCP3 gene is associated with body mass index in humans in interaction with physical activity. Diabetologia. 2000;43:245-9.
520. Lanouctte CM, Giacobino JP, Perusse L, et al. Association between uncoupling protein 3 gene and obesity-related phenotypes in the Quebec Family Study. Mol Med. 2001;7:433-41.
521. Cassell PG, Saker PJ, Huxtable SJ, et al. Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin. Diabetologia. 2000;43:1558-64.
522. Halsall D, Luan J, Saker P, et al. Uncoupling protein 3 genetic variants in human obesity: the c-55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population. Int J Obes Relat Metab Disord. 2001;25:472-7.
523. Yanagisawa Y, Hasegawa K, Dever GJ, et al. Uncoupling protein 3 and peroxisome proliferator-activated receptor gamma2 contribute to obesity and diabetes in Palauans. Biochem Biophys Res Commun. 2001;281:772-8.
524. Fisher RM, Burke H, Nicaud V, Ehnholm C, Humphries SE. Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. J Lipid Res. 1999;40:287-94.
525. Lefevre M, Lovejoy JC, DeFelice SM, et al. Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat. Int J Obes Relat Metab Disord. 2000;24:945-53.
526. Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, Gysin R. The Dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem Med Metab Biol. 1993;50:176-85.
527. Thomas GN, Tomlinson B, Critchley JA. Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. Hypertension. 2000;36:177-82.
528. Spitz MR, Detry MA, Pillow P, et al. Variant alleles of the D2 dopamine receptor gene and obesity. Nutr Res. 2000;20:371-80.
529. Tataranni PA, Baier L, Jenkinson C, Harper I, Del Parigi A, Bogardus C. A Ser311Cys mutation in the human dopamine receptor D2 gene is associated with reduced energy expenditure. Diabetes. 2001;50:901-4.
530. Siffert W, Naber C, Walla M, Ritz E. G protein beta 3 subunit 825T allele and its potential association with obesity in hypertensive individuals. J Hypertens. 1999;17:1095-8.
531. Siffert W, Forster P, Jockel K, et al. Worldwide ethnic distribution of the G protein beta 3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol. 1999;10:1921-30.
532. Hegele RA, Anderson C, Young TK, Connelly PW. G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res. 1999;9:972-7.
533. Gutersohn A, Naber C, Muller N, Erbel R, Siffert W. G protein beta3 subunit 825 TT genotype and post-pregnancy weight retention. Lancet. 2000;355:1240-1.
534. Hocher B, Slowinski T, Stolze T, Pleschka A, Neumayer HH, Halle H. Association of maternal G protein beta3 subunit 825T allele with low birthweight. Lancet. 2000;355:1241-2.
535. Sun G, Gagnon J, Chagnon Y, et al. Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE family study. Int J Obes Relat Metab Disord. 1999;23:929-35.
536. Acton S, Osgood D, Donoghue M, et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol. 1999;19:1734-43.
537. Aubert R, Betoulle D, Herbeth B, Siest G, Fumeron F. 5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people. Int J Obes Relat Metab Disord. 2000;24:920-4.
538. Chagnon YC, Chen WJ, Pérusse L, et al. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Québec Family Study. Mol Med. 1997;3:663-73.
539. Rosmond R, Chagnon M, Bouchard C, Björntorp P. A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol. Diabetologia. 2001;44:1335-8.
540. Zee RYL, Lou YK, Morris BJ. Insertion variant in intron 9, but not microsatellite in intron 2, of the insulin receptor gene is associated with essential hypertension. J Hypertens. 1994;12:S13-S22.
541. Zee RYL, Griffiths LR, Morris BJ. Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertensives. Biochem Biophys Res Commun. 1992;189:965-71.
542. Zee RYL, Schrader AP, Robinson BG, Griffiths LR, Morris BJ. Association of HincII RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives. Clin Genet. 1995;47:118-21.
543. Griffiths LR, Nyhold DR, Curtain RP, Gaffney PT, Morris BJ. Cross-sectional study of a microsatellite marker in the low density lipoprotein receptor gene in obese normotensives. Clin Exp Phannacol Physiol. 1995;22:496-8.
544. Rutherford S, Nyholt D, Curtain R, et al. Association of a low density lipoprotein receptor microsatellite variant with obesity. Int J Obes Relat Metab Disord. 1997;21:1032-7.
545. Mattevi VS, Coimbra CE Jr, Santos RV, Salzano FM, Hutz MH. Association of the low-density lipoprotein receptor gene with obesity in Native American populations. Hum Genet. 2000;106:546-52.
546. Magré J, Laurell H, Fizames C, et al. Human hormone-sensitive lipase. Genetic mapping, identification of a new dinucleotide repeat, and association with obesity and NIDDM. Diabetes. 1998;47:284-6.
547. Hoffstedt J, Arner P, Schalling M, et al. A common hormone-sensitive lipase i6 gene polymorphism is associated with decreased human adipocyte lipolytic function. Diabetes. 2001;50:2410-3.
548. Pihlajamaki J, Valve R, Karjalainen L, Karhapaa P, Vauhkonen I, Laakso M. The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance. Eur J Clin Invest. 2001;31:302-8.
549. Oh JY, Barrett-Connor E. Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study. Clin Genet. 2001;60:132-7.
550. Orho-Melander M, Almgren P, Kanninen T, Forsblom C, Groop L. A paired-sibling analysis of the Xbal polymorphism in the muscle glycogen synthase gene. Diabetologia. 1999;42:1138-45.
551. Bottini E, Gloria-Bottini F. Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus. Metabolism. 1999;48:949-51.
552. Evans D, Aberle J, Wendt D, Wolf A, Beisiegel U, Mann WA. A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J Mol Med. 2001;79:198-204.
553. Yuan X, Yamada K, Ishiyama-Shigemoto S, Koyama W, Nonaka K. Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia. 2000;43:373-6.
554. Wilson AF, Elston RC, Tran LD, Siervogel RM. Use of the robust sib-pair method to screen for single-locus, multiple-locus, and pleiotropic effects: application to traits related to hypertension. Am J Hum Genet. 1991;48:862-72.
555. Chagnon YC, Pérusse L, Lamothe M, et al. Suggestive linkages between markers on human 1p32-p22 and body fat and insulin levels in the Quebec Family Study. Obes Res. 1997;5:115-21.
556. van der Kallen CJ, Cantor RM, van Greevenbroek MM, et al. Genome scan for adiposity in Dutch dyslipidemic families reveals novel quantitative trait loci for leptin, body mass index and soluble tumor necrosis factor receptor superfamily 1A. Int J Obes Relat Metab Disord. 2000;24:1381-91.
557. Norman R, Tataranni P, Pratley R, et al. Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet. 1998;62:659-68.
558. Pérusse L, Rice T, Chagnon Y, et al. A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec Family Study. Diabetes. 2001;50:614-21.
559. Weyer C, Wolford JK, Hanson RL, et al. Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21-q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol Genet Metab. 2001;72:231-8.
560. Bailey-Wilson JE, Wilson AF, Bamba V. Linkage analysis in a large pedigree ascertained due to essential familial hypercholesterolemia. Genet Epidemiol. 1993;10:665-9.
561. Delplanque J, Barat-Houari M, Dina C, et al. Linkage and association studies between the proopiomelanocortin (POMC) gene and obesity in Caucasian families. Diabetologia. 2000;43:1554-7.
562. Comuzzie AG, Hixson JE, Almasy L, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet. 1997;15:273-6.
563. Rotimi CN, Comuzzie AG, Lowe WL, Luke A, Blangero J, Cooper RS. The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes. 1999;48:643-4.
564. Hager J, Dina C, Francke S, et al. A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet. 1998;20:304-8.
565. Comuzzie AG, Funahashi T, Sonnenberg G, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab. 2001;86:4321-5.
566. Norman RA, Thompson DB, Foroud T, et al. Genome wide search for genes influencing percent body fat in Pima Indians: suggestive linkage at chromosome 11q21-q22. Am J Hum Genet. 1997;60:166-73.
567. Watanabe RM, Ghosh S, Langefeld CD, et al. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet. 2000;67:1186-200.
568. Kissebah A, Sonnenberg G, Myklebust J, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A. 2000;97:14478-83.
569. Borecki IB, Rice T, Pérusse L, Bouchard C, Rao DC. An exploratory investigation of genetic linkage with obesity phenotypes: the Quebec Family Study. Obes Res. 1994;2:213-9.
570. Clément K, Dina C, Basdevant A, et al. A sib-pair analysis study of 15 candidate genes in French families with morbid obesity-indication for linkage with islet 1 locus on chromosome 5q. Diabetes. 1999;48:398-402.
571. Clément K, Philippi A, Jury C, et al. Candidate gene approach of familial morbid-obesity-linkage analysis of the glucocorticoid receptor gene. Int J Obes Relat Metab Disord. 1996;20:507-12.
572. Walder K, Morris C, Ravussin E. A polymorphism in the gene encoding CART is not associated with obesity in Pima Indians. Int J Obes Relat Metab Disord. 2000;24:520-1.
573. Bray MS, Boerwinkle E, Hanis CL. Linkage analysis of candidate obesity genes among the Mexican-American population of Starr County, Texas. Genet Epidemiol. 1999;16:397-411.
574. Chagnon YC, Borecki IB, Perusse L, et al. Genome-wide search for genes related to the fat-free body mass in the Quebec Family Study. Metabolism. 2000;49:203-7.
575. Lapsys NM, Furler SM, Moore KR, et al. Relationship of a novel polymorphic marker near the human obese (OB) gene to fat mass in healthy women. Obes Res. 1997;5:430-3.
576. Clément K, Garner C, Hager J, et al. Indication for linkage of the human OB gene region with extreme obesity. Diabetes. 1996;45:687-90.
577. Duggirala R, Stern MP, Mitchell BD, et al. Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am J Hum Genet. 1996;59:694-703.
578. Onions K, Hunt S, Rutkowski M, et al. Genetic markers at the leptin (OB) locus are not significantly linked to hypertension in African Americans. Hypertension. 1998;31:1230-4.
579. Reed DR, Ding Y, Xu W, Cather C, Green ED, Price RA. Extreme obesity may be linked to markers flanking the human OB gene. Diabetes. 1996;45:691-4.
580. Roth H, Hinney A, Ziegler A, et al. Further support for linkage of extreme obesity to the obese gene in a study group of obese children and adolescents. Exp Clin Endocrinol Diabetes. 1997;105:341-4.
581. Hsueh WC, Mitchell BD, Schneider JL, et al. Genome-wide scan of obesity in the Old Order Amish. J Clin Endocrinol Metab. 2001;86:1199-205.
582. Mitchell B, Cole S, Comuzzie A, et al. A quantitative trait locus influencing BMI maps to the region of the beta-3 adrenergic receptor. Diabetes. 1999;48:1863-7.
583. Chagnon YC, Rice T, Perusse L, et al. Genomic scan for genes affecting body composition before and after training in Caucasians from HERITAGE. J Appl Physiol. 2001;90:1777-87.
584. Hinney A, Ziegler A, Oeffner F, et al. Independent confirmation of a major locus for obesity on chromosome 10. J Clin Endocrinol Metab. 2000;85:2962-5.
585. Price RA, Li WD, Bernstein A, et al. A locus affecting obesity in human chromosome region 10p12. Diabetologia. 2001;44:363-6.
586. Bouchard C, Pérusse L, Chagnon YC, Warden C, Ricquier D. Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Genet. 1997;6:1887-9.
587. Hanson RL, Ehm MG, Pettitt DJ, et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet. 1998;63:1130-8.
588. Ohnian M, Oksanen L, Kainulainen K, et al. Testing of human homologues of murine obesity genes as candidate regions in Finnish obese sib pairs. Eur J Hum Genet. 1999;7:117-24.
589. Ohman M, Oksanen L, Kaprio J, et al. Genome-wide scan of obesity in Finnish sibpairs reveals linkage to chromosome Xq24. J Clin Endocrinol Metab. 2000;85:3183-90.
590. Lee JH, Reed DR, Li WD, et al. Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet. 1999;64:196-209.
591. York B, Lei K, West DB. Sensitivity to dietary obesity linked to a locus on chromosome 15 in a CAST/Ei X C57BL/6J F2 intercross. Mamm Genome. 1996;7:677-81.
592. Dragani TA, Zeng ZB, Canzian F, et al. Mapping of body weight loci on mouse chromosome X. Mamm Genome. 1995;6:778-81.